| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,167 | 44,550 | 45,803 | 43,836 | | Cost of Revenue | 32,197 | 32,748 | 33,278 | 33,728 | | | Gross Profit | 9,970 | 11,802 | 12,525 | 10,108 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,530 | 3,533 | 3,558 | 3,955 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 397 | 411 | 415 | 412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,043 | 7,858 | 8,552 | 5,741 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 221 | 2 | (3,295) | | Earnings Before Interest And Taxes | 6,044 | 8,079 | 8,554 | 2,446 | | Interest Expense | 4,598 | 4,661 | 4,598 | 4,630 | | Income Before Tax | 1,446 | 3,418 | 3,956 | (2,184) | | Income Tax Expense | 586 | 1,384 | 1,602 | (531) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 860 | 2,034 | 2,354 | (1,653) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (166) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 860 | 2,034 | 2,354 | (1,819) | | Preferred Stock And Other Adjustments | (4) | (3) | (4) | 8 | | | Net Income Applicable To Common Shares | $856 | $2,031 | $2,350 | ($1,811) |
|
0.51% Nasdaq 
0.04 (1.02%) 
Income Statement
